Rebus Biosystems Expands Scientific Advisory Board with Key Appointments
SANTA CLARA, CA – March 17, 2022 – Rebus Biosystems Inc, (“Rebus Bio”, “Rebus”), an Illumina Ventures-backed life science technology company creating revolutionary tools to advance spatial omics research, announced today that Arnold Kriegstein, M.D., PhD. and Kun Zhang, PhD., have been appointed to the Company’s Scientific Advisory Board (SAB). Both Drs. Kriegstein and Zhang bring vast experience that will inform new applications in spatial biology on Rebus’ technology platform.
Read more